Heart Valve Development: Regulatory Networks in Development and Disease

In recent years, significant advances have been made in the definition of regulatory pathways that control normal and abnormal cardiac valve development. Here, we review the cellular and molecular mechanisms underlying the early development of valve progenitors and establishment of normal valve structure and function. Regulatory hierarchies consisting of a variety of signaling pathways, transcription factors, and downstream structural genes are conserved during vertebrate valvulogenesis. Complex intersecting regulatory pathways are required for endocardial cushion formation, valve progenitor cell proliferation, valve cell lineage development, and establishment of extracellular matrix compartments in the stratified valve leaflets. There is increasing evidence that the regulatory mechanisms governing normal valve development also contribute to human valve pathology. In addition, congenital valve malformations are predominant among diseased valves replaced late in life. The understanding of valve developmental mechanisms has important implications in the diagnosis and management of congenital and adult valve disease.

[1]  J. Graham.  Hypoplastic Left Heart Syndrome Links to Chromosomes 10q and 6q and Is Genetically Related to Bicuspid Aortic Valve , 2010 .

[2]  K. Yutzey,et al.  VEGF and RANKL Regulation of NFATc1 in Heart Valve Development , 2009, Circulation research.

[3]  P. Byers,et al.  Molecular mechanisms of classical Ehlers‐Danlos syndrome (EDS) , 2009, Human mutation.

[4]  K. Mesbah,et al.  Signaling Pathways Controlling Second Heart Field Development , 2009, Circulation research.

[5]  T. Mikawa,et al.  FGFR-1 is required by epicardium-derived cells for myocardial invasion and correct coronary vascular lineage differentiation. , 2009, Developmental biology.

[6]  B. Neel,et al.  Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation , 2009, Proceedings of the National Academy of Sciences.

[7]  Jae-Hoon Choi,et al.  Brief Definitive Report Identifi Cation of Antigen-presenting Dendritic Cells in Mouse Aorta and Cardiac Valves , 2022 .

[8]  F. Schoen.  Evolving Concepts of Cardiac Valve Dynamics , 2009 .

[9]  S. Bleyl,et al.  Development of the Heart , 2009 .

[10]  J. Molkentin,et al.  Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome , 2008, Proceedings of the National Academy of Sciences.

[11]  B. Black,et al.  BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[12]  R. Schwartz,et al.  Frs2α-deficiency in cardiac progenitors disrupts a subset of FGF signals required for outflow tract morphogenesis , 2008, Development.

[13]  J. Klingensmith,et al.  An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart , 2008, Development.

[14]  Frederick J. Schoen,et al.  Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering , 2008, Circulation.

[15]  R. Hinton,et al.  Scleraxis Is Required for Cell Lineage Differentiation and Extracellular Matrix Remodeling During Murine Heart Valve Formation In Vivo , 2008, Circulation research.

[16]  K. Kadler,et al.  Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[17]  Bruce J Aronow,et al.  Shared gene expression profiles in developing heart valves and osteoblast progenitor cells. , 2008, Physiological genomics.

[18]  Ju Chen,et al.  A myocardial lineage derives from Tbx18 epicardial cells , 2008, Nature.

[19]  Bin Zhou,et al.  Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart , 2008, Nature.

[20]  R. Hinton,et al.  Mouse heart valve structure and function: echocardiographic and morphometric analyses from the fetus through the aged adult. , 2008, American journal of physiology. Heart and circulatory physiology.

[21]  A. Karsan,et al.  Notch Signaling in Cardiac Development , 2008, Circulation research.

[22]  Elaine L. Shelton,et al.  Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. , 2008, Developmental biology.

[23]  R. Markwald,et al.  Periostin regulates atrioventricular valve maturation. , 2008, Developmental biology.

[24]  R. Markwald,et al.  Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart , 2008, Circulation research.

[25]  D. Stainier,et al.  High-speed imaging of developing heart valves reveals interplay of morphogenesis and function , 2008, Development.

[26]  M. Seibel,et al.  Osteoblasts Directly Control Lineage Commitment of Mesenchymal Progenitor Cells through Wnt Signaling* , 2008, Journal of Biological Chemistry.

[27]  R. Mecham,et al.  New insights into elastic fiber assembly. , 2007, Birth defects research. Part C, Embryo today : reviews.

[28]  V. Joag,et al.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. , 2007, The American journal of pathology.

[29]  B. Toole,et al.  Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. , 2007, Developmental biology.

[30]  Victoria Bolós,et al.  Monitoring Notch1 activity in development: Evidence for a feedback regulatory loop , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[31]  Roger R Markwald,et al.  Valvulogenesis: the moving target , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[32]  D. Severac,et al.  Signalling Pathways Involved in Adult Heart Formation Revealed by Gene Expression Profiling in Drosophila , 2007, PLoS genetics.

[33]  H. Sucov,et al.  Msx1 and Msx2 regulate survival of secondary heart field precursors and post-migratory proliferation of cardiac neural crest in the outflow tract. , 2007, Developmental biology.

[34]  Mauro W. Costa,et al.  Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. , 2007, American journal of human genetics.

[35]  D. Srivastava,et al.  Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. , 2007, Circulation.

[36]  Roger R Markwald,et al.  Transitions in Early Embryonic Atrioventricular Valvular Function Correspond With Changes in Cushion Biomechanics That Are Predictable by Tissue Composition , 2007, Circulation research.

[37]  R. Kist,et al.  Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. , 2007, Developmental biology.

[38]  B. Gelb,et al.  The genetics of congenital heart disease: a review of recent developments , 2007, Current opinion in cardiology.

[39]  A. Moorman,et al.  Role of bone morphogenetic proteins in cardiac differentiation. , 2007, Cardiovascular research.

[40]  Alexander Nyström,et al.  Laminin isoforms in development and disease , 2007, Journal of Molecular Medicine.

[41]  R. Hinton,et al.  BMP and FGF regulatory pathways in semilunar valve precursor cells , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[42]  H. Dietz,et al.  Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice , 2007, Circulation research.

[43]  Katherine E Yutzey,et al.  Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. , 2007, Developmental biology.

[44]  V. Gaussin,et al.  Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. , 2007, Developmental biology.

[45]  Ralph Weissleder,et al.  Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease , 2007, Circulation.

[46]  K. Yutzey,et al.  ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[47]  F. Schoen,et al.  Human Pulmonary Valve Progenitor Cells Exhibit Endothelial/Mesenchymal Plasticity in Response to Vascular Endothelial Growth Factor-A and Transforming Growth Factor-&bgr;2 , 2006, Circulation research.

[48]  C. Tabin,et al.  Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. , 2006, Developmental biology.

[49]  Tomoki Nakamura,et al.  Neural Crest Cells Retain Multipotential Characteristics in the Developing Valves and Label the Cardiac Conduction System , 2006, Circulation research.

[50]  K. Yutzey,et al.  Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. , 2006, Developmental biology.

[51]  R. Hinton,et al.  Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.

[52]  V. Garg,et al.  Molecular genetics of aortic valve disease , 2006, Current opinion in cardiology.

[53]  R. Bonow,et al.  Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. , 2006, Journal of the American College of Cardiology.

[54]  K. Yutzey,et al.  BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. , 2006, Developmental biology.

[55]  K. Yutzey,et al.  NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K. , 2006, Developmental biology.

[56]  R. Markwald,et al.  An In Vivo Analysis of Hematopoietic Stem Cell Potential: Hematopoietic Origin of Cardiac Valve Interstitial Cells , 2006, Circulation research.

[57]  F. Schoen,et al.  Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to Adult: Implications for Postnatal Adaptation, Pathology, and Tissue Engineering , 2006, Circulation.

[58]  E. Canalis,et al.  Notch 1 Overexpression Inhibits Osteoblastogenesis by Suppressing Wnt/β-Catenin but Not Bone Morphogenetic Protein Signaling* , 2006, Journal of Biological Chemistry.

[59]  S. Najjar,et al.  Echocardiographic findings in classical and hypermobile Ehlers–Danlos syndromes , 2006, American journal of medical genetics. Part A.

[60]  B. Paw,et al.  Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[61]  R. Schwartz,et al.  Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning , 2005, Development.

[62]  J. Schalkwijk,et al.  Tenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[63]  M. Frasch,et al.  The Dorsocross T-box genes are key components of the regulatory network controlling early cardiogenesis in Drosophila , 2005, Development.

[64]  K. Yutzey,et al.  Noonan Syndrome Mutation Q79R in Shp2 Increases Proliferation of Valve Primordia Mesenchymal Cells via Extracellular Signal–Regulated Kinase 1/2 Signaling , 2005, Circulation research.

[65]  B. Fontaine,et al.  Schwartz-Jampel syndrome and perlecan deficiency. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[66]  Heather Verkade,et al.  Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development , 2005, Development.

[67]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[68]  S. Stock,et al.  Atorvastatin Inhibits Hypercholesterolemia-Induced Calcification in the Aortic Valves via the Lrp5 Receptor Pathway , 2005, Circulation.

[69]  B. J. Martinsen,et al.  Reference guide to the stages of chick heart embryology , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[70]  R. Norris,et al.  Normal distribution of melanocytes in the mouse heart. , 2005, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[71]  Frederick J Schoen,et al.  Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[72]  Rosario V. Freeman,et al.  Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.

[73]  F. Dagenais,et al.  Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. , 2005, The Journal of heart valve disease.

[74]  W. Roberts,et al.  Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.

[75]  Raymond B. Runyan,et al.  Frzb modulates Wnt-9a-mediated beta-catenin signaling during avian atrioventricular cardiac cushion development. , 2005, Developmental biology.

[76]  D. Ornitz,et al.  Sequential roles of Hedgehog and Wnt signaling in osteoblast development , 2004, Development.

[77]  B. Rongish,et al.  The extracellular matrix during heart development , 1995, Experientia.

[78]  Frederick J Schoen,et al.  Heart valve regeneration. , 2005, Advances in biochemical engineering/biotechnology.

[79]  Raymond B. Runyan,et al.  Cell biology of cardiac cushion development. , 2005, International review of cytology.

[80]  A. Weyman,et al.  Marfan syndrome and mitral valve prolapse. , 2004, The Journal of clinical investigation.

[81]  L. Silver,et al.  Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development , 2004, Development.

[82]  Robert H. Anderson,et al.  Lineage and Morphogenetic Analysis of the Cardiac Valves , 2004, Circulation research.

[83]  Randy L. Johnson,et al.  Targeted Disruption of hesr2 Results in Atrioventricular Valve Anomalies That Lead to Heart Dysfunction , 2004, Circulation research.

[84]  Joyce Bischoff,et al.  Heart valve development: endothelial cell signaling and differentiation. , 2004, Circulation research.

[85]  Frederick J Schoen,et al.  Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. , 2004, The Journal of heart valve disease.

[86]  E. Dejana,et al.  -Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse , 2004 .

[87]  Lisa J. Martin,et al.  Bicuspid aortic valve is heritable. , 2004, Journal of the American College of Cardiology.

[88]  A. Moorman,et al.  Dynamic patterns of expression of BMP isoforms 2, 4, 5, 6, and 7 during chicken heart development. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[89]  M. McKee,et al.  Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins , 2004, The Journal of cell biology.

[90]  Katherine E Yutzey,et al.  Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[91]  R. Markwald,et al.  Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. , 2004, Developmental biology.

[92]  K. Yutzey,et al.  Differential Expression and Function of Tbx5 and Tbx20 in Cardiac Development* , 2004, Journal of Biological Chemistry.

[93]  J. Epstein,et al.  Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Jie Wu,et al.  Noonan syndrome–associated SHP2/PTPN11 mutants cause EGF‐dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation , 2004, Human mutation.

[95]  J. Borer,et al.  The epidemiology of valvular heart diseases: the problem is growing. , 2004, Advances in cardiology.

[96]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.

[97]  J. Epstein,et al.  Molecular markers of cardiac endocardial cushion development , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[98]  David Sedmera,et al.  Developmental anatomy of the heart: a tale of mice and man. , 2003, Physiological genomics.

[99]  B. Hogan,et al.  An essential role of Bmp4 in the atrioventricular septation of the mouse heart. , 2003, Genes & development.

[100]  E. Délot,et al.  Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. , 2003, Molecular genetics and metabolism.

[101]  Robert H. Anderson,et al.  DEVELOPMENT OF THE HEART: (1) FORMATION OF THE CARDIAC CHAMBERS AND ARTERIAL TRUNKS , 2003, Heart.

[102]  David C. Lee,et al.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling , 2003, Journal of Molecular Medicine.

[103]  Roger R Markwald,et al.  Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. , 2003, Developmental biology.

[104]  J. Rodríguez-León,et al.  Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: Sox genes and BMP signaling. , 2003, Developmental biology.

[105]  A. Tajik,et al.  Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype , 2003, Circulation.

[106]  N. Ahmad,et al.  Prevalence of mitral valve prolapse in Stickler syndrome , 2003, American journal of medical genetics. Part A.

[107]  F. Schoen,et al.  NFATc1 Mediates Vascular Endothelial Growth Factor-induced Proliferation of Human Pulmonary Valve Endothelial Cells* , 2003, The Journal of Biological Chemistry.

[108]  Gabriel Acevedo-Bolton,et al.  Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis , 2003, Nature.

[109]  K. Lyons,et al.  BMP signaling is required for septation of the outflow tract of the mammalian heart , 2003, Development.

[110]  E. Cuppen,et al.  The Wnt/beta-catenin pathway regulates cardiac valve formation. , 2003, Nature.

[111]  Raymond B. Runyan,et al.  Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. , 2002, Developmental biology.

[112]  S. Klewer,et al.  Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.

[113]  M. Bonnin,et al.  Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons. , 2002, Developmental biology.

[114]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[115]  P. Libby,et al.  Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.

[116]  N A Brown,et al.  Septation and valvar formation in the outflow tract of the embryonic chick heart , 2001, The Anatomical record.

[117]  D. Stainier,et al.  UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. , 2001, Science.

[118]  R. Kim,et al.  Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. , 2001, Developmental biology.

[119]  P. Carmeliet,et al.  A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. , 2001, Development.

[120]  R. Markwald,et al.  Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation , 2001, Mechanisms of Development.

[121]  C. Loffredo.  Epidemiology of cardiovascular malformations: prevalence and risk factors. , 2000, American journal of medical genetics.

[122]  J. McDonald,et al.  Hyaluronan: is bigger better? , 2000, American journal of respiratory cell and molecular biology.

[123]  H. Yost,et al.  Structure and function of the developing zebrafish heart , 2000, The Anatomical record.

[124]  A. Nagy,et al.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. , 2000, Development.

[125]  S. Klewer,et al.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.

[126]  Raymond B. Runyan,et al.  Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. , 2000, Developmental biology.

[127]  A. McMahon,et al.  Fate of the mammalian cardiac neural crest. , 2000, Development.

[128]  T. Magnuson,et al.  Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis , 2000, Nature Genetics.

[129]  S. Hokari,et al.  Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: Roles of transforming growth factor (TGF)‐β and bone morphogenetic protein (BMP) , 2000, The Anatomical record.

[130]  M. Gimbrone,et al.  A role for Smad6 in development and homeostasis of the cardiovascular system , 2000, Nature Genetics.

[131]  R. Timpl,et al.  Perlecan Maintains the Integrity of Cartilage and Some Basement Membranes , 1999, The Journal of cell biology.

[132]  J. Rossant,et al.  Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. , 1999, Developmental biology.

[133]  Raymond B. Runyan,et al.  Slug is a mediator of epithelial-mesenchymal cell transformation in the developing chicken heart. , 1999, Developmental biology.

[134]  R. Markwald,et al.  The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. , 1998, Developmental biology.

[135]  A. Copp,et al.  Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. , 1998, Circulation research.

[136]  Robert E. Poelmann,et al.  Development of the atrioventricular valve tension apparatus in the human heart , 1998, Anatomy and Embryology.

[137]  A. G. Gittenberger-de Groot,et al.  Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. , 1998, Circulation research.

[138]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[139]  R. Anderson,et al.  Formation of the atrioventricular septal structures in the normal mouse. , 1998, Circulation research.

[140]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[141]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[142]  S. Klewer,et al.  Expression of type VI collagen in the developing mouse heart , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[143]  A. Sinning.  Partial purification of HLAMP‐1 provides direct evidence for the multicomponent nature of the particulate matrix associated with cardiac mesenchyme formation , 1997, Journal of cellular biochemistry.

[144]  E. Clark,et al.  Developmental changes in the myocardial architecture of the chick , 1997, The Anatomical record.

[145]  M. Fishman,et al.  Fashioning the vertebrate heart: earliest embryonic decisions. , 1997, Development.

[146]  R. Jaenisch,et al.  Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[147]  H. Kuivaniemi,et al.  Mutations in fibrillar collagens (types I, II, III, and XI), fibril‐associated collagen (type IX), and network‐forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels , 1997, Human mutation.

[148]  Raymond B. Runyan,et al.  Antibodies to the Type II TGFbeta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. , 1996, Developmental biology.

[149]  F. Follis,et al.  Osteogenesis imperfecta and cardiovascular diseases. , 1995, The Annals of thoracic surgery.

[150]  R. Markwald,et al.  Transformation of cardiac endothelium into cushion mesenchyme is dependent on ES/130: temporal, spatial, and functional studies in the early chick embryo. , 1995, Cellular & molecular biology research.

[151]  P. Byers.  Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity. , 1994, The Journal of investigative dermatology.

[152]  H. Helminen,et al.  Mutations in Type 1 Procollagen That Cause Osteogenesis Imperfecta: Effects of the Mutations on the Assembly of Collagen into Fibrils, the Basis of Phenotypic Variations, and Potential Antisense Therapies , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[153]  R. Hynes,et al.  Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. , 1993, Development.

[154]  Patricia Spallone,et al.  Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.

[155]  R. Markwald,et al.  Identification of an extracellular 130-kDa protein involved in early cardiac morphogenesis. , 1993, The Journal of biological chemistry.

[156]  W. Tasman,et al.  Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[157]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[158]  R. Markwald,et al.  An antiserum (ES1) against a particulate form of extracellular matrix blocks the transition of cardiac endothelium into mesenchyme in culture. , 1991, Developmental biology.

[159]  B. Hogan,et al.  Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). , 1990, Development.

[160]  C. Little,et al.  Distribution of laminin, collagen type IV, collagen type I, and fibronectin in chicken cardiac jelly/basement membrane , 1989, The Anatomical record.

[161]  Raymond B. Runyan,et al.  Protein extracts from early embryonic hearts initiate cardiac endothelial cytodifferentiation. , 1985, Developmental biology.

[162]  R. Jaenisch,et al.  Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death , 1984, Cell.

[163]  D. Wilcken,et al.  Collagen composition of normal and myxomatous human mitral heart valves. , 1984, The Biochemical journal.

[164]  R. Markwald,et al.  Structural development of endocardial cushions. , 1977, The American journal of anatomy.

[165]  R. Markwald,et al.  Sturctural analysis of endocardial cytodifferentiation. , 1975, Developmental biology.